Future Protein-Ligand Challenges: CELPP & New Datasets · 2. Automated link between our webservices...

Post on 25-Jul-2020

0 views 0 download

Transcript of Future Protein-Ligand Challenges: CELPP & New Datasets · 2. Automated link between our webservices...

FutureProtein-LigandChallenges:CELPP&NewDatasets

VickiFeher

CELPPWeeklyautomatedcross-dockingchallengesenabledbyPDBreleaseofsmallmolecule&proteinsequencesWeenvisionthreepossiblewaystoparDcipate:

1.Dockingprogramhostedonourinternalserver2.Automatedlinkbetweenourwebservicesandanexternalautomated dockingwebsites3.Downloadingourweeklyposts&uploadingresults

CanwemovebeyondreproducingPDBstructureposes?

1.Workwiththejournals/PDBtohavenoDficaDonof“accepted”papers and“HOLD”structureswithaffiniDes.2.SGC-Torontowillprovide~1-2monthnoDceofdatasetsbeing preparedforpublicaDon

2

CELPPStatus

VWDJH���GDWDLPSRUW

VWDJH���JOLGH�VFRULQJ�52&6�506'�565�

VWDJH���EODVWQILOWHU

VWDJH���IUHG VWDJH���JOLGH

VWDJH���IUHG�VFRULQJ�52&6�506'�565�

SGEEODVWGE���GDWD�EODVW�RXWSXW�����

VWDJH���SGESUHS

VWDJH���ZHEGDWD VWDJH���H[W�QDPH�LG!

VWDJH���H[W�QDPH�LG!�VFRULQJ�52&6�506'�565�

VWDJH���UHVXOWZHEGDWD*UHHQ�ER[HV�DUH�FXUUHQWO\�FRPSOHWH�DQG�UXQQLQJ

VWDJH���FRPSLQFKL

SGEH[WUDFWHG��GDWD�SGE�H[WUDFWHG�����

&RPSOHWHG��EXW�ZLOO�EH�UHSODFHG�E\�LPSURYHG�YHUVLRQ

3

CELPPWeek

4

6XQGD\0RQGD\ 7XHVGD\ :HGQHVGD\ 7KXUVGD\ )ULGD\ 6DWXUGD\

�����SP��PDNHEODVWGE��GDWDLPSRUW��EODVWQILOWHU��SURWHLQOLJSUHS��ZHEGDWD��IUHG��JOLGH

&(/33�ZHHN

&(/33�ZHHN�VWDUW

�����SP�7XHVGD\�WR�������DP�6DWXUGD\1R�XVHU�VXEPLVVLRQV�DOORZHG�GXULQJ�WKLV�WLPH

������DP�6DWXUGD\�WR������SP�7XHVGD\�8VHU�VXEPLVVLRQV�DFFHSWHG

������DP�6DWXUGD\�WR������SP�7XHVGD\�8VHU�VXEPLVVLRQV�DFFHSWHG

������SP�� �HYDOXDWLRQ��UHVXOWZHEGDWD

7LPHV�DUH�LQ�3DFLILF�'D\OLJKW�7LPH*UD\HG�RXW�WH[W�LV�QRW�LPSOHPHQWHG

�����SP��SGEGRZQORDG

Stage2:BLAST-n-FilterWorkflow

Queryfilter•  #ofuniquesequences•  #ofdockableligands

Read.tsvfiles•  Filterligands

-  Dockable?

BLAST

Hitfilter•  %idenDty(#idenDcal/#aligned)•  %coverage(#aligned/#query)•  #ofuniquesequences•  Experimentalmethod

Candidatefilter•  LargestMCSS•  SmallestMCSS•  HighestresoluDonapo•  HighestresoluDonholo

Writelog Writesummary Postanalysis•  Parselog•  XLSX•  Resname,PNG

5

Numbersbyweek

6

0

50

100

150

200

2502015

2015

2015

2015

2015

2015

2015

2015

2015

2015

2015

2015

2015

2016

2016

2016

2016

2016

2016

2016

2016

2016

2016

41 42 43 44 45 46 47 48 49 50 51 52 53 1 2 3 4 5 6 7 8 9 10

Complexes

Dockablecomplexes

Dockablemonomers

TargetsFound

Stage4:Docking•  Currentonourserver

–  OEDocking–  CCDC:GOLD–  Schrodinger:Glide–  AutoDock

•  Outreachto–  Shoichet,DOCK3.7–  RobertRizzoDock6.7–  Jain,Surflex

•  EvaluaDonswillbesameasthoseforGrandChallengesandautomatedintheCELPPworkflow;RMSD,RSR,ROCS(orsometypeofinteracDonfingerprint)

7

Stage5:EvaluaDon

Feedback•  Ideasforhowbesttopostresults?

•  Whatsortofresultsshouldwepost?

•  WoulditbeusefultopostresultsrelaDvetousingvariousligandpreparaDonmethods?–  Ie.tautomerpredicDon,pKapredicDons

8

NextChallenges

ITK–GenentechdonaDon

FXR–RochedonaDon

FBPase–RochedonaDon

9

FarnesoidXreceptor(FXR)Roche

10

AnuclearreceptorinvolvedincholesterolandbileacidhomeostasisAntagonistsarepotenDaldyslipidemialoweringagentsandpotenDalTypeIIdiabetestreatmentsThebindingsiteishighlylipophilicandflexible4disDnctchemotypes+6miscellaneouscompoundsThereare~25+publishedcrystalstructures,includingexamplesofthesechemotypecrystalstructurespublished

Fructose-1,6-bisphosphataseRoche

11

Aproteininvolvedingluconeogenesis,convertsfructose-1,6-bisphosphatetofructose-2,6-bisphosphateTargetfordecreasingglucoseproducDonforTypeIIdiabetesAllostericallyregulated;thecompoundsaretargeDngtheallostericsite2chemotypes+somemiscellaneouscompoundsThereare~20+publishedcrystalstructures,includingexamplesofthesechemotypecrystalstructurespublished

D3RTeam

MikeGilson

MikeChiu

HuanwangYang JasmineYoung

JeffGrethe

RommieAmaro VickiFeherStephenBurley

SymonGathiaka ShuaiLiu JeffWagner

ChrisChuras

ThankstoPreviousDatasetDonors

•  Roche•  Genentech•  GSK•  Abbvie•  Vertex

13